The short-seller who uncovered Valeant has found his next target in health care

Citron Research’s Andrew Left, who gained notoriety for successful bets against companies such as Valeant Pharmaceuticals, posted a bearish report on cancer testing company Exact Sciences.
Shares of Exact Sciences closed down nearly 4 percent Monday after the short seller released his...
Click here to read the full article